Heng Lu

Second Military Medical University — China

Medicine · Health Sciences

18h-index896citations87works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(25), Pancreatic and Hepatic Oncology Research(18), Gastrointestinal Tumor Research and Treatment(18), Ferroptosis and cancer prognosis(15), Helicobacter pylori-related gastroenterology studies(14)

Publications87 total

Therapeutic Effects of a Low FODMAP Diet on Symptoms, Gut Microbiota, and Anxiety in Patients with Irritable Bowel Syndrome
Health psychology research·2026Open Access
Glutamine alleviates radiation-induced intestinal injury in rats via the mTOR/Notch1 axis
Frontiers in Oncology·2026Open Access
1111: TARGETING APE1-REDOX FUNCTION REVERSES SOX9-MEDIATED CHEMORESISTANCE IN ESOPHAGEAL ADENOCARCINOMA
Gastroenterology·2025
925: REGULATION OF EPITHELIAL CELL FATE AND TUMORIGENESIS IN THE EARLY STAGES OF ESOPHAGEAL ADENOCARCINOMA
Gastroenterology·2025
Su1308: APE1/NF-κB/PRDX2 ACTIVATED BY REFLUX CONDITIONS MEDIATES CHEMORESISTANCE IN ESOPHAGEAL ADENOCARCINOMA BY SUPPRESSING FERROPTOSIS
Gastroenterology·2025
Abstract 542: Chronic gastroesophageal reflux promotes chemoresistance in esophageal adenocarcinoma through APE1-redox-dependent PRDX2 activation and ferroptosis inhibition
Cancer Research·2025
Abstract 3847: APE1 mediates angiogenesis by stabilizing SMAD3 and blocking its ubiquitin induced degradation in esophageal adenocarcinoma
Cancer Research·2025
Abstract 6968: Targeting overexpressed NEK2 kinase in esophageal adenocarcinoma
Cancer Research·2025
Effects of <i>Bifidobacterium</i> triple viable bacteria-assisted mirtazapine in managing depression in patients after radical surgery for gastric cancer
World Journal of Gastrointestinal Surgery·2025· 4 citedOpen Access
Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors
International Journal of Molecular Sciences·2025· 5 citedOpen Access
Supplementary Table S3 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Figure S2 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Figure S3 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Table S2 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Figure S4 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Table S2 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Table S1 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Figure S4 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Supplementary Figure S3 from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
Data from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024Open Access
page 1 of 5Next →

Frequent Co-authors

Dunfa Peng(38), Zheng Chen(33), Wael El‐Rifai(28), Farah Ballout(19), Oliver G. McDonald(17), Mohammed Soutto(16), Nadeem S. Bhat(15), Lei Chen(15), Alexander Zaika(14), Shoumin Zhu(13), Jianwen Que(9), Wael El-Rifai(9), Silvia Giordano(9), Tianling Hu(8), Alexander Zaika(7), Alan S. Livingstone(7), Steven Chen(6), Xiaodian Sun(6), Simona Corso(6), Ajaz A. Bhat(5)